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Abstract 
Increasing prevalence of antibiotic resistance has led research to focus on discovering new 
antimicrobial agents derived from the marine biome. Although ample studies have investigated sponges 
for their bioactive metabolites with promising prospects in drug discovery, the potentiating effects of 
sponge extracts on antibiotics still remains to be expounded. The present study aimed to investigate the 
antibacterial capacity of seven tropical sponges collected from Mauritian waters and their modulatory 
effect in association with three conventional antibiotics namely chloramphenicol, ampicillin and 
tetracycline. Disc diffusion assay was used to determine the inhibition zone diameter (IZD) of the 
sponge total crude extracts (CE), hexane (HF), ethyl acetate (EAF) and aqueous (AF) fractions against  
nine standard bacterial isolates whereas broth microdilution method was used to determine their 
minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs) and 
antibiotic potentiating activity of the most active sponge extract. MIC values of the sponge extracts 
ranged from 0.039 to 1.25mg/mL. Extracts from Neopetrosia exigua rich in beta-sitosterol and 
cholesterol displayed the widest activity spectrum against the 9 tested bacterial isolates whilst the best 
antibacterial profile was observed by its EAF particularly against Staphylococcus aureus and Bacillus 
cereus with MIC and MBC values of 0.039 mg/mL and 0.078 mg/mL, respectively. The greatest 
antibiotic potentiating effect was obtained with the EAF of N. exigua (MIC/2) and ampicillin 
combination against S. aureus. These findings suggest that the antibacterial properties of the tested 
marine sponge extracts may provide an alternative and complementary strategy to manage bacterial 
infections. 
 
Keywords Antibacterial activity, Antibiotic potentiating, Marine sponges, Neopetrosia exigua, 
Mauritius 
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1. Introduction 
The optimism of the 1950s and 1960s of a world without infections is gradually being replaced by an 
era of pessimism characterized by widespread emergence of antimicrobial resistance (Raghunath 
2008). Even today, infectious diseases including HIV/AIDS, tuberculosis, and malaria continue to 
elude the prospect of morbidity and mortality worldwide killing around 700, 000 people annually 
(O’Neill 2016). Of particular concern is the high mortality rate associated with bacterial infections 
caused by methicillin-resistant Staphylococcus aureus (MRSA), extended spectrum β-lactamase 
(ESBL)-producing Enterobacteriaceae, vancomycin-resistant Enterococcus, penicillin-resistant 
Streptococcus pneumonia as well as multi drug resistant (MDR) Salmonella (Farooqui et al. 2015). 
According to the World Health Organisation “this is happening at a time when too few new drugs are 
being discovered vis à vis antimicrobial resistance” (WHO, 1996). Clearly, the reduced effectiveness of 
the current catalogue of clinically useful antibiotics motivates research for identifying novel molecules 
with antimicrobial properties to stem the tide against antimicrobial resistance. 
 
Contributing to the global search for new antibiotics, natural products have historically been pharma’s 
treasure trove for drug hunters (Newman and Cragg 2010). Drug discovery from natural sources has 
recently shifted to the marine biome which hosts a vast repertoire of biodiversity. Among marine 
organisms, sponges have been widely described as important producers of secondary metabolites with 
novel structural features and bioactivity (Sipkema et al. 2005). These organisms are sessile 
invertebrates which compensate for their lack of physical defence by producing chemicals indicating 
their ecological significance as anti-predation, competition for space and control of epibiont 
overgrowth (Majik et al. 2014). Sponge-associated microbiome, including bacteria, archaea, and fungi 
also play a role in the production of these compounds (Beesoo et al. 2014). These chemical adaptations 
involve chemical classes such as terpenes, sterols, cyclic peptides, alkaloids, fatty acids, peroxides, 
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amino acid derivatives and halogenated metabolites (Sipkema et al. 2005). In the marine environment, 
antimicrobial and antifouling metabolites prevent sessile organisms such as sponges to host hazardous 
biofilms on their exposed surfaces (Majik et al. 2014). Hence, antimicrobial compounds isolated from 
sponges may represent an alternative source of novel antibiotics which can be used to supply the 
starved pharmaceutical market. 
 
About 800 antimicrobial compounds have been isolated from sponges, a few of which has 
demonstrated potentials as promising therapeutic leads such as manzamine A and psammaplin A.  
Pharmaceutical interest in sponges was aroused in the early 1950s by the discovery of the nucleosides 
Ara-C, the first marine-derived anticancer agent, and the antiviral drug Ara-A from the marine sponge 
Cryptotethia crypta (Laport et al. 2009). These early promises have now been substantiated by a 
growing number of sponge derived compounds such as discodermolide (Martello et al. 2001), 
spongistatin 1 (Schyschka et al. 2008), laulimalide (Bajaj and Srayko 2013) that have also shown 
synergistic interactions with conventional anticancer drugs. Synergism of drug therapy and natural 
products may also give optimum results in the fight against existing and emerging infectious diseases. 
Regarding the application of natural products on bacterial infections, besides their direct antimicrobial 
activity, natural extracts have also been studied as antimicrobial drug resistance modifiers. Thus, 
various combinations of these extracts with synthetic antibiotics have been tested against bacterial 
proliferation, and many studies have demonstrated that compounds present in the extracts can modify 
the activity of antibiotics, increasing their efficacy (Coutinho et al. 2011; Morais Braga et al. 2012; 
Souza et al. 2012; Matias et al. 2013). 
 
With most research in the area of marine natural product chemistry being conducted in Atlantic and 
Pacific Ocean regions, it is becoming increasingly important to survey the fauna of isolated regions of 
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the globe for new chemotherapeutic agents (Leal et al. 2012). The Mascarene Islands (Mauritius, 
Rodrigues and Reunion) are the most isolated of the tropical marine flora and fauna of the South-west 
Indian Ocean and represent an extremely fertile reservoir of genetic and metabolic novelties 
(Beedessee et al. 2015). In our continuous exploration of antimicrobial agents from the marine 
ecosystem, the aims of this study were to evaluate the in vitro antibacterial activity of the total crude 
extracts, hexane, ethyl acetate and aqueous fractions from seven sponge species which are strongly 
represented in the Mascarene regions namely Neopetrosia exigua, Aaptos chromis, Iotrochota 
birotulata, Haliclona tuberosa, Spheciospongia sp., Biemna fortis and Halichondria sp. We also aimed 
to determine the antibiotic potentiating effect of the most active sponge extract in association with 
chloramphenicol, ampicillin and tetracycline. The present work is anticipated to establish important 
baseline information on the antibacterial properties of the studied sponges and preliminary data on the 
chemical constituents of the most active sponge extract. 
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2. Material and methods 
 
2.1 Sampling and Identification 
Seven sponge samples namely Neopetrosia exigua, Aaptos chromis, Iotrochota birotulata, Haliclona 
tuberosa, Spheciospongia sp, Biemna fortis and Halichondria sp were collected at Amber Island 
(20°03'52.5"S and 57°41'19.7"E) on the northeast coast of Mauritius island in February 2013 (Figure 
1). The sponges were collected at depth varying from 1-2 metres by snorkelling. They were transferred 
in sterile polyethene bags under sea water to the lab, cleaned of debris and frozen at -80°C prior to 
freeze drying and extraction. Taxonomic identification of the sponge species was made using the 
World Porifera Database (World Porifera Database, 2016). 
 
2.2 Extraction and creation of fraction libraries 
The sponges were cut into small pieces, weighed, freeze dried and ground into powder. The freeze 
dried sponge (250–1000g) was exhaustively macerated with methanol and dichloromethane (1:1) for 
48 h. After maceration, the solution was filtered and evaporated to dryness on a rotatory vacuum 
evaporator set at a temperature of 37°C (LABORATA 4003, Heidolph, Germany).  This constituted the 
crude extract, which was suspended in distilled water to be partitioned subsequently with n-hexane and 
ethyl acetate to afford non-polar, semi-polar and polar fractions respectively. The extracts were 
weighed and stored at −20°C until used. 
 
2.3 Microorganisms 
The microbial strains were obtained from American Type Culture Collection (ATCC): Bacillus cereus 
(ATCC 11778), Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922), Pseudomonas 
aeruginosa (ATCC 27853), Pseudomonas fluorescens (ATCC 13525), Klebsiella oxytoca (ATCC 
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43086), Klebsiella pneumoniae (ATCC 13883), Salmonella enterica (ATCC 29986) and Serratia 
marcescens (ATCC 14756). All isolates were maintained on nutrient agar slants at 4°C. The strains 
were activated by subculture at 37°C for 24 h with fresh Muller Hinton Agar (MHA) prior to any 
antimicrobial tests. 
 
2.4 Preparation of inoculums 
The inoculum size of the test isolates was standardized according to the Clinical Laboratory Standards 
Institute guidelines (CLSI, 2008). Briefly, the bacteria were inoculated in Muller Hinton Broth (MHB) 
and were incubated at 37°C for 24 h.  The turbidity of the bacterial suspension was adjusted to match 
the tube of 0.5 McFarland turbidity standards at 600 nm using the spectrophotometer on a Helios-Alpha 
spectrophotometer (Unicam Ltd., UK) which equals to 1.5 × 10
8 
colony-forming units (CFU)/mL. This 
was used for the standardisation of the antibacterial assay. 
 
 
2.5 Antibacterial agar disc diffusion assay 
 
The in vitro antibacterial activity of the marine extracts total crude extracts and fractions was evaluated 
via the disc diffusion method using Müeller–Hinton agar with determination of inhibition zones 
diameter measured in millimeter (mm) (CLSI, 2008). Sterile filter paper discs (6 mm) were 
impregnated with 10 µL of sponge extracts and then placed on inoculated Petri dishes containing 0.1 
ml bacterial suspension adjusted to 1.5 × 10
8 
CFU/mL. Chloramphenicol, ampicillin and tetracycline 
pre-dosed at 50 μg/mL per disc were used as positive control whereas discs without samples (5% 
DMSO (dimethyl sulfoxide) acted as negative control. The zones of inhibition including the diameter 
of the extract impregnated dics were compared with those of the controls after incubation at 37°C for 
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24 h. The inhibition zone diameter (IZD) was used as criteria for the definition of active or inactive 
sponge extracts. The tests were carried out in triplicate for each extract. 
 
 
2.6 Determination of minimal inhibitory concentration (MIC) 
Sponge extracts which showed the ability to inhibit the growth of microorganisms used in the present 
study (IZD > 8 mm) were tested for their minimum inhibitory concentration (MIC) by the 
microdilution technique (Eloff 1998). The extracts were diluted with 5% dimethyl sulfoxide to obtain 
concentrations from 0.0195 to 2.5 mg/mL. 100 µL of the extracts dilutions were placed into a 96-well 
microplate and inoculated with 100 µL of each bacterial strain at a density adjusted to 0.5 of the 
McFarland scale (1.5 × 10
8
 CFU/mL). The microplate was incubated at 37°C for 24 h. The p-
Iodonitrotetrazolium chloride (0.2 mg/mL) was used as an indicator of microbial growth. Viable 
bacteria reduced the yellow dye to a purple colour. The MIC was defined as the lowest concentration of 
extract that inhibits bacterial growth. This test was performed in triplicates. Chloramphenicol, 
ampicillin and tetracycline (stock concentration: 2.048 mg/mL) were used as positive control.  
 
2.7 Minimum Bactericidal Concentration (MBC) 
Sponge extracts which showed antibacterial activity below100 µg/mL were further assessed for their 
minimum bactericidal concentration (MBC). MBC is the smallest concentration of the drug necessary 
for elimination of 99.9% of the microorganisms tested. To establish MBC of the extracts, 20 µl of each 
culture medium with no visible growth was removed from each well and inoculated in MHA agar 
plates. After 16–20h of incubation at 37 °C, the number of surviving organisms was determined. If 
MIC = MBC or if MBC = 1, 2 or 3 dilutions above MIC, the activity is considered bactericidal 
(Isenberg 1992).  
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2.8 Antibiotic potentiating assay 
Sponge extract/fraction showing significant antibacterial activities as compared to the positive controls 
in the previous assays was associated with conventional antibiotics in view of evaluating any possible 
synergistic effect as previously described (Tankeo et al. 2015). In this experiment, a preliminary study 
(using the microbroth dilution assay) of the bacteria tested (E. coli, P. fluorescens, S. aureus, and B. 
cereus) with chloramphenicol, ampicllin and tetracycline were investigated to select the sub inhibitory 
MIC at which the experiment will be performed. Briefly, the sponge extract was tested at sub inhibitory 
concentrations of MIC/2 and MIC/4 in association with antibiotics against each bacterial isolate.  
Fractional inhibitory concentration (FIC) was calculated as the ratio of MIC Antibiotic in combination/MIC 
Antibiotic alone and the results were discussed as follows: synergy (≤0.5), indifferent (>0.5 to 4), or 
antagonism (>4). All assays were performed in triplicate. 
 
2.9 Gas chromatography–mass spectrometry (GC–MS) analyses of the ethyl acetate (EAF) 
fraction of N. exigua 
The EAF fraction of N. exigua was analyzed by GC–MS coupled to an Agilent MS model 6975 C MSD 
with triple axis detector (Agilent Technologies, USA). The GC column is a 30 m HP5-MS column 
made from (5%-phenyl)-methylpolysiloxane (i.d.= 0.25mm, df=0.25μm). 1 mg of the N. exigua EAF 
fraction was weighed and added to 20μL pyridine and 50μL of BSTFA (with 1% TMCS). The prepared 
sample was then incubated at 60 °C for 1 hour in order to yield trimethylsilyl derivatives (TMSi) of the 
compounds in the sample (Abulaimi 2017). Sample derivatization was carried out at GC initial 
temperature of 240°C for 3 minutes and incremented to 280°C for 25 minutes at a rate of 20°C/min. 
The mass spectrometer operated using an electron ionization source at 70eV. The ion source 
temperature was 230°C. Analysis preceded using MSD ChemStation and by matching the MS spectra 
of the peaks with those stored in the NIST 2011 Mass Spectral Library (Agilent Technologies, USA).   
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2.9 Data Analysis 
 
All experiments were conducted in triplicate and statistical analyses were conducted using analysis of 
variance (ANOVA). The results were expressed as means of triplicate determinations ± standard 
deviation (SD). The confidence limits used in this study were based on 95% (p < 0.05). The software 
SPSS v.19 (SPSS-IBM, Orchard Road-Armonk, New York, NY, USA) was used for statistical 
analysis. 
 
3. Results 
3.1 Antibacterial agar disc diffusion assay  
All of the 28 sponge total crude extracts and fractions screened for antibacterial activity showed 
significant activity against at least one bacterial strain ranging from weak to strong activities based on 
the following arbitrary criterion: Very-weak-6-8 mm, weak-8-12 mm, good-12-16 mm, and strong > 16 
mm inhibition activities respectively (Table 3.1). 17 and 22 of the total crude extracts and fractions 
exhibited very weak and weak antibacterial activity respectively. On the other hand, 11 extracts showed 
good antibacterial activities while 2 displayed strong propensity. EAF of N. exigua gave the most 
potent action spectra yielding the largest IZD particularly against the Gram-positive S. aureus (19.57 ± 
0.25 mm). The antibacterial potential of this sponge fraction was comparable to that of ampicillin 
(20.47 ± 1.75 mm) but significantly better than chloramphenicol (17.73 ± 0.64 mm) and tetracycline 
(17.43 ± 0.40
 
mm) (p < 0.05). CE and EAF of N. exigua inhibited B. cereus significantly with IZD of 
17.74 ± 0.60 mm and 18.36 ± 0.66 mm respectively compared to the positive control tetracycline 
(16.20 ± 1.18
 
mm). Inhibitory efficacy of EAF N. exigua was similarly more pronounced on E. coli 
(IZD: 15.80 ± 1.91 mm) than tetracycline (IZD: 12.77 ± 1.15 mm) and statistically similar (IZD: 15.47 
± 0.42
 
mm) to chloramphenicol (IZD: 16.07 ± 0.31 mm) against P. fluorescens. Besides extracts of N. 
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exigua, CE of I. birotulata also showed significantly comparable antibacterial activity (IZD: 14.60 ± 
0.53
 
mm) to tetracycline (IZD: 14.27 ± 0.31 mm) against P. fluorescens (p < 0.05).  
 
Significant differences in antimicrobial activity were found among the crude extracts and solvent 
fractions (P < 0.05). While the sponge total crude extracts showed minimal antibacterial, selected sub 
fractions of extracts showed promising results against the pathogens. In most cases, EAFs revealed 
stronger antibacterial activities while AFs exhibited weaker activities. It was also generally observed 
that Gram-positive B. cereus and S. aureus were the most susceptible bacteria to the sponge extracts 
while P. pneumonia and E. coli were the most resistant Gram-negative strains. 
 
3.2 Minimum Inhibitory Concentration 
The antibacterial activity of each sponge extract with IZD greater than 8 mm was further probed to 
determine its MIC using the micro-dilution assay. The sponge extracts exhibited antibacterial activity 
within a range of concentrations of 0.039 to 1.25 mg/mL (Table 3.2). N. exigua had the most potent 
antibacterial activity with its EAF displaying MIC values below 100 µg/mL particularly against S. 
aureus (0.039 mg/mL), B. cereus (0.039 mg/mL), E. coli (0.78 mg/mL), P. fluorescens (0.78 mg/mL). 
These MIC values were in some cases better or comparable to the reference antibiotics used in the 
present study. Furthermore, CE of I. birotulata also inhibited the growth of P. fluorescens with MIC 
value (0.078 mg/mL) lower than tetracycline (0.128 mg/mL). The overall MIC results of the sponge 
extracts confirmed the screening done by the disc diffusion method.  
 
3.3 Minimum Bactericidal Concentration (MBC) 
Result from the MBC assay (Table 3.2) showed that EAF of N. exigua possessed bactericidal activities 
against E. coli (0.625 mg/mL), P. fluorescens (0.313 mg/mL), B. cereus (0.078 mg/mL) and S. aureus 
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(0.078 mg/mL). Bactericidal activity was also registered by CE of N. exigua towards S. aureus and B. 
cereus with MBC value of 0.312 mg/mL. CE of I. birotulata was however bacteriostatic against P. 
fluorescens (MBC> 2.5 mg/mL).  
 
3.4 Antibiotic potentiating effect 
Based on its low MIC values, EAF of N. exigua was selected to further determine its antibiotic 
potentiating activity at sub inhibitory concentrations MIC/2 and MIC/4 against selected bacterial strains 
including E. coli, P. fluorescens, B. cereus and S. aureus. A synergistic effect was observed in most of 
the different combinations when associated with chloramphenicol, ampicillin and tetracycline as 
indicated by the FIC values (Table 3.3).  
However, when the concentrations of EAF of N. exigua were varied, the synergistic effect observed 
was not same for all the bacteria. In some cases the synergistic activity was enhanced in a dose 
dependent manner but in others there was a decrease or no change in activity as compared to the MIC 
values of the antibiotics alone. For instance, when chloramphenicol was associated with EAF of N. 
exigua at MIC/4 and assessed against P. fluorescens the MIC value decreased from 0.064 to 0.016 
mg/mL but when the concentration of the sponge extract was doubled (MIC/2) there was still a 
decrease in MIC compared to the MIC of chloramphenicol alone.  
On the other hand, when chloramphenicol and ampicillin were associated with the sponge extract at 
both MIC/4 and MIC/2 against B. cereus and S. aureus respectively, a decrease in the MIC value of the 
antibiotic was observed but within the two doses, the MIC values remained unchanged (Table 3.3).  
Furthermore, EAF of N. exigua when combined with ampicillin at both concentrations did not show 
any improvement in activity against E. coli (0.064 mg/mL) and P. fluorescens (0.016 mg/mL) as 
compared to the MIC values of the antibiotic alone. Similarly the combination of the sponge extract 
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and tetracycline resulted in indifferent effects against E. coli (0.256 mg/mL). Overall, the most 
significant increase in antibiotic activity in the presence of the sponge extract was noted with the EAF 
N. exigua (MIC/2) and ampicillin combination on S. aureus, (MIC: 0.004 mg/mL; FIC: 0.125) with a 
four-fold decrease of the MIC value of the antibiotic alone (0.032 mg/mL). 
 
3.5 Chemical constituents of the EAF of N. exigua 
Preliminary chemical screening of EAF of the sponge N. exigua was performed using GC–MS.  The 
number and nature of chemical constituents in the sponge EAF as depicted by the peaks were 
characterized and identified by comparing the mass spectra of the constituents with NIST library 
(Figure 2). Table 4 lists the compound names, retention time and percentage compositions. Overall, 13 
TMSi derivatives of compounds (1-13) were detected including fatty acids (n-hexadecanoic acid (1), 
trans-9-octadecenoic acid trimethylsilyl ester (2)), and sterols (cholesterol trimethylsilyl ether (7), 
silane, [(3.beta.)-cholesta-5,24-dien-3-yloxy]trimethyl (9), silane, [[(3.beta., 24R)-ergost-5-en-3-
yl]oxy]trimethyl- (10), beta-sitosterol trimethylsilyl ether (13)). Of all these compounds, beta-sitosterol 
trimethylsilyl ether (13) was identified as the most significant component of the EAF representing 
23.9%.  
 
4. Discussion 
The emergence of multiple drug resistance in human pathogenic microorganisms has added momentum 
to search for new antimicrobial substances from natural sources. There have been several mechanisms 
proposed for the antibacterial activity of potent drugs including natural extracts (Kumar et al. 2014). In 
many cases, natural extracts can be more effective than chemically synthesized pure compounds 
because they are a complex mixture of components. Their complexity enables them to interact with 
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multiple molecular targets thus conveying accrued difficulty for target microorganisms to develop 
resistance due to multiple response sites (Lagunin et al. 2016). Intensive efforts during the past decades 
have led to the discovery of promising antimicrobial extracts and compounds from marine organisms. 
In particular marine sponges have been recently the subject of several antimicrobial screening studies 
worldwide (Tangman et al. 2015; Putra et al. 2016). Here, we present data indicating the antibacterial 
efficacy and antibiotic potentiating activity of crude extracts and fractions obtained from seven tropical 
sponges from Mauritius waters. 
 
The diversity in antimicrobial activity shown by natural extracts is usually subjected to differences in 
their chemical concentration and composition (Smolskaite et al. 2015).  In general, the total CEs 
demonstrated smaller IZDs and higher MIC values as compared to the HFs and EAFs. The MIC of 
crude extracts is rarely found to be < 0.1 mg/ml but with more refined fractions or individual 
compounds, MICs of < 0.1 mg/ml may be reflective of good antimicrobial activity and thus can be 
considered worthy for further investigations (Webster et al. 2007). However, it is striking that the total 
CE of I. birotulata demonstrated noteworthy antibacterial activity (MIC: 0.078 mg/mL) as compared to 
its fractions with MIC values below 0.1 mg/mL. This may potentially suggest a synergistic effect 
arising from several compounds present in the total CEs could account for the high antibacterial 
activities. It is noteworthy that a number of antimicrobial compounds have been isolated and 
characterised from the genus Iotrochota, such as the alkaloids purpurones (Shen et al. 2012). Other 
sulphated alkaloids are baculiferins isolated from the Chinese marine sponge I. baculifera. Baculiferins 
were found to be potent inhibitors against HIV IIB in both MT4 and MAGI cells (Fan et al. 2010). 
 
Of all the marine crude extracts and fractions, EAF of N. exigua displayed the greatest antibacterial 
effect with the largest IZD and lowest MIC/MBC values. The antibacterial effect of EAF of N. exigua 
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was more pronounced against the Gram positive bacteria S. aureus and B. cereus with IZD and MIC 
values comparable to the reference antibiotics used in the present study (Table 3.1 and 3.2). This is 
quite remarkable considering that antibiotics are in the purified and concentrated form whereas the 
extracts are crude and may harbour both pharmacologically and non-pharmacologically active 
compounds with the chance of some compounds having a masking effect over others (Njume et al. 
2011). This is an indication that the EAF of N. exigua may contain therapeutically useful compounds 
against S. aureus and B. cereus associated infections (Tangman et al. 2015).  
A medley of studies performed on marine sponges of the genus Neopetrosia showed that several 
compounds conferring antimicrobial potencies were isolated from its extracts. Leone et al (2008) 
isolated exiguaquinol from the sponge N. exigua which inhibited the bacterial enzymes Helicobacter 
pylori (Glutamate racemase that inter converts L- and D- glucose) needed for the construction of 
bacterial cell walls. Renieramycin J, tetrahydroisoquinoline alkaloid and araguspongine M, both of 
which showed strong antifungal activities were also isolated from the same species from Japanese 
waters. A Synechococcus-like cyanobacterium has been detected in the tissue of N. exigua by visible 
and fluorescent microscopic observations (Oku et al. 2003). Hence these compounds or their precursors 
may be produced by these symbiotic microorganisms. 
 
From the foregoing findings, it was observed that the extracts had more pronounced effect on the 
Gram-positive bacteria than the Gram-negative bacteria. This is in congruence with most of the 
available reports on antibacterial property of sponges that revealed that Gram-positive bacteria are 
more susceptible to sponge extracts as compared to Gram negative ones (Liu et al. 2004). Extracts 
derived from 28 marine sponge species collected along the French coast had high antibacterial activity 
against Gram positive bacteria (77%) than Gram negative bacteria (53%) (Lippert et al. 2003). 
Moreover, McCaffrey and Endean (Amade et al. 1987) also showed that Gram-positive bacteria were 
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more sensitive to sponge extracts of subtropical and tropical species than Gram-negative. Similarly in 
this study, the Gram positive S. aureus and B. cereus exhibited higher sensitivity as compared to the 
Gram-negative bacteria. Gram-negative bacteria K. pneumoniae and E. coli were most resistant to the 
tested extracts possibly because of the outer membrane consisting of lipoprotein and 
lipopolysaccharide, which is selectively permeable and thus regulates access to antimicrobial 
compounds (McCaffrey et al. 1987).  
 
Bacterial resistance can occur against natural extracts/compounds as well thereby increasing the need 
to develop newer and more powerful therapies to combat resistant microorganisms. Therefore, a novel 
concept which has recently been explored is the synergism between known antimicrobial drugs and 
bioactive natural products. This therapy can be employed to expand the antimicrobial spectrum, to 
prevent the surfacing of bacterial mutants and to minimize toxicity, thereby exhibiting antimicrobial 
action greater than what would be normally expected from each individual antibiotic (Chopra and 
Greenwood, 2001). Synergy between marine natural products and antimicrobial drugs has been 
frequently reported.  Song et al. (2010) showed that 7-O-methylkoninginin D and trichodermaketones 
A-D isolated from the marine-derived fungus Trichoderma koningii, combined with ketoconazole 
showed synergistic antifungal activity against Candida albicans. Another study led by Choi et al. 
(2015) demonstrated that fucoidans isolated from brown seaweeds drastically enhanced the 
antibacterial activity of oxacillin and ampicillin to combat MRSA.  Additionally the methanolic extract 
of the seaweed Eisenia bicyclis also influenced the activity of erythromycin and lincomycin and thus 
may be used as adjuvant in antibiotic therapy against acne-related bacteria (Choi et al. 2015). 
 
In the present study, based on the evidence of EAF of N. exigua as a strong antimicrobial, its 
potentiating effect was further assessed against E. coli, P. fluorescens, S. aureus and B. cereus using 
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chloramphenicol, ampicillin and tetracycline. Overall, the highest synergistic activity was observed by 
EAF of N. exigua (MIC/2) and ampicillin against S. aureus suggesting that EAF of N. exigua may have 
potential for use as an adjunct in the treatment of S. aureus related bacterial infections. This finding is 
particularly pertinent as multi-drug resistant strains of this microorganism are on the rise in both 
hospital and community environments against orthodox antibiotics and its control is very difficult by 
therapeutic means (Tangman et al. 2015).  
 
The continuous increasing susceptibility of several antibiotics to bacterial resistance including 
ampicillin, tetracycline and chloramphenicol has been recently confirmed by official reports of the 
Center for Disease Dynamics, Economics and Policy (CDDEP, 2015). The resistance mechanisms 
against these drugs include: reduction of the cell membrane permeability, enzyme degradation, and 
activation of efflux pumps. Therefore, the synergistic effects that have been achieved by the association 
of EAF of N. exigua with these antibiotics could be related to an increase in drug influx, because a set 
of constituents present in the extracts, might exert a destabilizing effect on the bacterial cell wraps, 
causing increased permeability to tested antibiotics and thus, potentiating their effect (Lee et al. 2014). 
Of note, at present no other study regarding the antibiotic modulatory effect of marine sponges has 
been reported, as well as, additional studies aimed at identifying the molecular mechanism underlying 
the antimicrobial property of this sponge extract remain to be carried out. 
 
So far, the GC-MS analysis of the EAF of N. exigua has revealed two previously identified 
antibacterial compounds namely hexadecanoic acid (and its derivatives) and β-sitosterol. Hexadecanoic 
acid is one of the most common saturated fatty acids found in animals and plants and has shown 
antibacterial activity against a panel of pathogenic bacteria including Staphylococcus aureus, 
Escherichia coli and Salmonella sp (Zong hui et al. 2010). Similarly Abou-Elela and his colleagues 
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reported the antibacterial activity of hexadecanoic acid derivatives isolated from the sponge Spongia 
officinalis and the brown algae Cytosoria compressa against S. aureus, S. faecalis, P. aeruginosa and 
E.coli (Abou-Elela et al. 2009). β-sitosterol (23.9%) which is known for its pluri-pharmacological 
properties (Saeidnia et al. 2014) was predominant. Subramaniam et al. (2014) reported promising 
antibacterial activity of β-sitosterol derivatives particularly against E. faecalis, S. dysenteriae, and P. 
aeruginosa (MIC: 10-15 µg/ml) and its synergistic activity with commonly used antibiotics such as 
ciprofloxacin, polymyxin B and chloramphenicol. This molecule has been an interesting lead for 
chemical and biological investigations and over the years, several modified β-sitosterol have been 
isolated (Ododo et al. 2016, Subramaniam et al 2014, Sanches et al. 2005). Sponges of the genus 
Neopetrosia are still yielding novel bioactive molecules; neopetrocyclamines A and B (Liang et al., 
2015), 9'-epi-3β, 3'β-dimethylxestospongin C (Li et al., 2011) and exiguamine A (Brastianos et al., 
2006) and this was the impetus for the investigation of a member of this genus.  Liquid 
chromatography-MS analyses of the active EAF of N. exigua will be carried out with the aim to 
identify other constituents (undetected by GC-MS) contributing to its antibacterial property. Further 
bioassay guided fractionation will also be needed to isolate and identify the active constituents present 
in this extract and elucidate their mode of action. 
 
5. Conclusion 
This study demonstrated the antibacterial effects of seven sponge crude extracts and fractions, in 
addition to the synergistic action against numerous bacterial strains when combined with conventional 
antibiotics. Among the sponge species investigated N. exigua was the most promising species tested, 
advocating the possibility of finding potent antibacterial agents particularly from its ethyl acetate 
fraction. However, it must be emphasized that interactions between natural products and synthetic 
drugs depend on several factors including pharmacokinetics and employed doses and therefore, 
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combinations established in vitro may not have the same effect in vivo or in clinical trials. Further 
research should be undertaken to ensure the safety and efficacy of the sponge extracts by delineating 
the active constituents in the extract. Overall, the implication of this study opens a new and fertile area 
of future research to pursue in search of novel antimicrobial lead compounds. In this perspective, 
further in depth studies are warranted to elucidate the molecular mechanisms underlying the 
antibacterial effects of the marine extracts which may yield more insights into their chemotherapeutic 
as potential antimicrobial agents. 
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Table 1 Inhibition Zone Diameter (mm) of the sponge total crude extracts and fractions using the agar disc diffusion assay 
Sponge species/ 
Standard 
Antibiotics 
Extracts 
(10µL/Disc) 
Inhibition Zone Diameter (mm) 
Gram negative bacteria Gram positive bacteria 
E.c P.f P.a K.o K.p S.m S.e B.c S.a 
Neopetrosia  
exigua 
CE 11.40±0.53
c 
12.47±0.42
de 
9.67±1.16
b 
13.16±0.23
d 
7.86±0.39
d 
12.20±1.01
c 
10.64±0.56
h 
17.74±0.60
c 
15.33±0.32
b 
HF 11.70±0.36
c 
11.97±0.35
e 
10.57±0.57
b 
14.36±0.46
c 
8.60±0.36
c 
10.60±0.60
d,e 
11.34±0.27
g 
14.50±0.35
e 
14.53±0.25
b 
EAF 15.80±1.91
b 
15.47±0.42
b 
11.43±0.45
b 
14.74±0.15
c 
9.64±0.34
c 
14.10±0.36
c 
12.02±0.19
f 
18.36±0.66
c 
19.57±0.25
a 
AF 10.67±2.08
c 
12.97±0.25
d 
7.20±0.62
c,d 
9.82±0.29
h 
6.48±0.22
d 
7.97±0.85
e,f 
7.08±0.58
m 
14.22±0.64
e,f 
11.40±0.46
e 
Iotrochota  
birotulata 
CE 7.33±0.58
d 
14.60±0.53
c 
7.57±1.04
c,d 
11.54±0.29
f 
ND 10.30±1.37
d,e 
8.58±0.27
j,k 
12.10±0.46
g 
13.50±0.44
d 
HF 7.60±1.28
d 
11.97±0.65
e 
7.00±0.30
c,d 
10.56±0.48
g 
ND 12.30±0.30
c,d 
8.00±0.25
k 
13.08±0.34
f,g 
14.03±2.61
b 
EAF 8.37±1.00
d 
11.33±0.42
f 
9.70±0.20
b 
9.56±0.22
h,i 
ND 14.47±0.42
c 
8.40±0.30
j,k 
14.44±0.50
e 
14.83±0.55
c 
AF 6.70±0.89
d 
6.13±0.12
j 
6.60±0.30
d 
7.22±0.36
k,l 
ND 6.53±0.61
f 
6.64±0.19
n 
7.46±0.18
k 
7.00±0.61
g 
Aaptos  
chromis 
CE ND 9.13±0.15
g 
ND 10.62±0.23
g 
ND 8.40±0.35
e 
9.38±0.19
i 
12.72±0.18
f,g
 14.33±0.45
c 
HF ND 10.07±0.31
g 
ND 8.44±0.42
j 
ND 9.50±0.30
e 
10.36±0.13
h 
10.88±0.75
h 
10.30±0.44
e 
EAF ND 11.23±0.32
f 
ND 8.16±0.25
j,k 
ND 7.23±0.32
e,f 
13.50±0.39
e 
14.44±0.38
e 
14.50±0.46
c 
AF ND 7.37±0.35
i 
ND 6.80±1.16
l,m 
ND 6.20±0.36
f 
6.64±0.17
n 
8.62±0.36
j 
8.17±0.21
f 
Biemna  
fortis 
CE ND 8.20±0.0.20
h 
ND 10.30±0.29
g,h 
ND ND 6.80±0.34
m,n 
11.69±0.44
h 
10.20±0.17
e 
HF ND 10.10±0.56
g 
ND 11.46±0.19
f 
ND ND 7.56±0.19
l,m 
12.32±0.18
g,h 
14.77±0.93
c 
EAF ND 10.93±0.40
f 
ND 11.16±0.23
f,j 
ND ND 9.50±0.28
i 
14.34±0.25
e,f 
13.80±0.80
c,d 
AF ND 6.20±0.20
j 
ND 6.98±0.27
l 
ND ND ND 7.42±0.19
k 
6.10±0.10
h 
Spheciospongia  
sp 
CE ND 8.30±0.30
h 
ND 8.46±0.21
j 
ND ND 8.36±0.18
j,k 
12.62±0.66
g 
13.23±0.21
d 
HF ND 9.10±0.56
h 
ND 8.76±0.19
i,j 
ND ND 8.72±0.29
j 
12.38±0.83
g 
8.43±0.38
f 
EAF ND 12.00±0.50
e 
ND 9.04±0.21
j 
ND ND 9.18±0.26
i 
12.88±0.36
f,g 
11.40±0.53
e 
AF ND ND ND ND ND ND ND 6.72±0.25
h 
6.37±0.35
g 
Haliclona  
tuberosa 
CE ND 6.20±0.20
j 
ND 7.46±0.21
k,l 
ND ND 8.18±0.33
k 
11.90±0.66
g,h 
8.17±0.45
f 
HF ND 7.30±0.44
i 
ND 7.76±0.19
k 
ND ND 7.16±0.34
m 
6.70±0.31
k 
9.23±0.21
f 
EAF ND 10.20±0.20
g 
ND 8.24±0.11
j,k 
ND ND 7.80±0.16
k,l 
12.08±0.40
g,h 
11.27±1.03
e 
AF ND 6.30±0.36
j 
ND ND ND ND ND 6.92±0.31
k 
6.37±0.35
g 
Halichondria  
sp 
CE ND ND ND ND ND ND ND 8.82±0.36
j 
7.37±0.12
g 
HF ND ND ND ND ND ND ND 7.52±0.24
k 
8.42±0.33
f 
EAF ND ND ND ND ND ND ND 9.76±0.40
i 
9.50±0.36
f 
AF ND ND ND ND ND ND ND 6.82±0.15
k 
6.27±0.29
g 
Chl  14.50±0.87
b 
16.07±0.31
b 
16.33±1.63
a 
20.80±1.30
a 
16.80±0.84
b 
16.40±0.40
b 
18.00±0.71
b 
20.40±1.34
b 
17.73±0.64
b 
Amp  18.27±1.12
a 
21.10±0.26
a 
18.40±0.56
a 
17.40±1.52
b 
20.20±0.84
a 
20.17±1.76
a 
21.20±0.84
a 
22.20±1.84
a 
20.47±1.75
a 
Tet  12.67±1.15
c 
14.27±0.31
c 
17.17±0.78
a 
20.40±1.14
a 
17.60±1.14
b 
17.30±0.35
b 
16.00±0.71
c 
16.20±1.18
d 
17.43±0.40
b 
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Values are the mean of three independent determinations N.B: E.c (Escherichia coli); P.f (Pseudomonas fluorescens); P.a (Pseudomonas aeruginosa); K.o 
(Klebsiella oxytoca);  K.p (Klebsiella pneumoniae);  S.m (Serratia marcescens); S.e (Salmonella enterica);  B.a  (Bacillus cereus); S.a (Staphylococcus aureus) ; Chl: 
Chloramphenicol, Amp: Ampicillin, Tet: Tetracycline; CE: Crude extract; HF: Hexane fraction; EAF: Ethyl acetate fraction; AF: Aqueous fraction;  (ND): Not 
Detected. Note: Diameter of inhibition zones include diameter of discs (6mm). For each bacterium, different letters in the same column indicate significant 
differences (p < 0.05) between the mean values.
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Table 2 Minimum Inhibitory/Bactericidal Concentration of the most efficacious sponge total crude extracts and fractions. 
Sponge 
Species/ 
Standard 
antibiotics 
Sponge 
extracts 
Minimum Inhibitory/Bactericidal  
Concentrations (mg/mL) 
 
Gram-negative  
bacteria 
 
Gram-positive 
bacteria 
E.c 
 
P.f P.a K.o K.p S.m S.e B.c S.a 
Neopetrosia 
exigua 
CE 0.313 0.156 NT 0.156 1.25 0.313 0.625 (0.078) 
(0.312) 
BC 
(0.078) 
(0.312) 
BC 
HF 0.313 0.313 >2.5 0.313 0.625 0.156 0.313 0.156 0.156 
 
EAF (0.078) 
(0.625) 
BC 
(0.078) 
(0.312) 
BC 
1.25 0.156 0.313 0.156 0.156 (0.039) 
(0.078) 
BC 
(0.039) 
(0.078) 
BC 
AF 0.625 0.313 NT 0.313 NT 1.25 NT 0.156 0.313 
 
Iotrochota 
birotulata 
CE NT 0.078 
(>2.5) 
BS 
- 0.313 NT 0.625 1.25 0.313 0.313 
 
HF NT 0.313 - 0.313 NT 0.313 NT 0.313 0.156 
 
EAF >2.5 0.313 - 0.625 0.625 0.156 0.625 0.156 0.156 
 
AF NT 0.625 - NT - NT NT NT NT 
 
Aaptos  
chromis 
CE - 0.312 
 
- 0.313 - >2.5 1.25 0.313 0.156 
 
HF - 1.25 - 1.25 - NT 0.625 0.625 0.313 
 
EAF - 0.313 - 0.625 - 0.625 0.156 0.156 0.156 
 
AF - NT - NT - NT NT 0.625 1.25 
 
Biemna  
fortis 
CE - >2.5 - 1.25 - - NT 0.625 0.625 
 
HF - 1.25 - 0.625 - - NT 0.313 0.156 
 
EAF - 0.625 - 0.313 - - 0.313 0.156 0.156 
 
AF - NT - NT - - - NT NT 
 
Spheciospongia  
sp 
CE - >2.5 - >2.5 - - >2.5 0.313 0.625 
 
HF - 1.25 - >2.5 - - >2.5 NT 0.625 
 
EAF - 0.313 - 0.625 - - 1.25 0.313 0.313 
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AF - - - - - - - NT NT 
 
Haliclona  
tuberosa 
CE - NT - NT - - >2.5 0.625 1.25 
 
HF - NT - NT - - NT NT 0.625 
 
EAF - 0.625 -  - - NT 0.625 0.313 
 
AF - NT - - - - - - - 
 
Chl  0.128 
(0.256) 
BC 
0.064 
(0.512) 
BS 
0.128 
(0.512) 
BC 
0.016 
(0.128) 
BC 
0.128 
(0.256) 
BC 
0.032 
(0.256) 
BC 
0.032 
(0.128) 
BC 
0.016 
(0.016) 
BC 
0.064 
(0.064) 
BC 
Amp  0.064 
(0.256) 
BC 
0.016 
(0.128) 
BC 
0.064 
(0.256 
BC 
0.032 
(0.064) 
BC 
0.064 
(0.128) 
BC 
0.016 
(0.064) 
BC 
0.016 
(0.032) 
BC 
0.016 
(0.128) 
BC 
0.032 
(0.128) 
BC 
Tet  0.256 
(0.512) 
BS 
0.128 
(>0.512) 
BS 
0.128 
(>0.512) 
BS 
0.032 
(>0.512) 
BS 
0.064 
(0.128) 
BC 
0.064 
(0.128) 
BC 
0.064 
(0.256) 
BC 
0.064 
(0.512) 
BC 
0.064 
(0.256) 
BC 
 
Values are the mean of three independent determinations N.B: E.c (Escherichia coli); P.f (Pseudomonas fluorescens); P.a 
(Pseudomonas aeruginosa); K.o (Klebsiella oxytoca); K.p (Klebsiella pneumoniae); S.m (Serratia marcescens); S.e 
(Salmonella enterica); B.a (Bacillus cereus); S.a (Staphylococcus aureus). CE: Crude Extract; HF: Hexane Fraction; EAF: 
Ethyl acetate Fraction; AF: Aqueous Fraction; Chl: Chloramphenicol, Amp: Ampicillin, Tet: Tetracycline; (-): Not 
evaluated because marine extract did not show any inhibitory effect (MIC) upto 2.5 mg/ml. NT: Not tested because marine 
extract showed an inhibitory effect with inhibition zone <8 mm by disc diffusion method. (): MBC value (mg/mL). BS: 
Bacteriostatic; BC: Bacteriocidal. Values in bold represent significant antibacterial activity of the sponge crude extracts or 
fractions. 
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Table 3 Antibiotic potentiating activity of EAF N. exigua  
Antibiotics
 
Concentration of EAF N. 
exigua (mg/mL) 
 
Bacterial strains, MIC (mg/mL) of antibiotics in the absence and presence 
of EAF N. exigua extract and FIC in parenthesis 
E.c P.f 
 
S.a B.c 
Chl 0 0.128 
 
0.064 0.064 0.016 
MIC/4 0.064 
(0.5)
S 
0.016 
(0.25)
S 
0.032 
(0.5)
S
 
0.008 
(0.5)
S
 
 MIC/2 0.032 
(0.25)
S
 
0.032 
(0.5)
S
 
0.016 
(0.25)
S
 
0.008 
(0.5)
S
 
Amp 0 0.064 
 
0.016 0.032 0.016 
MIC/4 0.064 
(1)
I 
0.016 
(1)
I 
0.008 
(0.25)
S 
0.004 
(0.25)
S 
 MIC/2 0.064 
(1)
I 
0.016 
(1)
I 
0.004 
(0.125)
S 
0.004 
(0.25)
S 
Tet 0 
 
0.256 
 
0.128 0.064 0.064 
MIC/4 0.256 
(1)
I 
0.064 
(0.5)
S
 
0.032 
(0.5)
S
 
0.032 
(0.5)
S
 
 MIC/2 0.256 
(1)
I 
0.064 
(0.5)
S
 
0.016 
(0.25)
S 
0.016 
(0.25)
S
 
 
Values are the mean of three independent determinations. N.B: Chl: Chloramphenicol, Amp: Ampicillin, Tet: Tetracycline; 
Bacterial strains: E.c (Escherichia coli); P.f (Pseudomonas fluorescens); B.a (Bacillus cereus); S.a (Staphylococcus aureus); 
Potentiating effect: S; Indifferent: I (-); FIC: Fractional Inhibitory Concentration. 
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      Table 4 Chemical constituents of EAF of N. exigua detected by GC-MS. 
 
Peak Retention time 
(min) 
Compound name Relative 
percentage ± 
SD  
1 3.571 Hexadecanoic acid, trimethylsilyl ester 1.8±0.5 
2 4.515 trans-9-Octadecenoic acid, trimethylsilyl ester 2.0±0.1 
3 4.627 Octadecanoic acid, trimethylsilyl ester 0.5±0.0 
4 5.605 Hexanedioic acid, bis(2-ethylhexyl) ester 6.8±1.0 
5 6.767 Bis(2-ethylhexyl) phthalate 22.6±0.2 
6 8.598 1-Monooleoylglycerol trimethylsilyl ether 0.5±0.3 
7 15.71 Cholesterol trimethylsilyl ether 16.2±1.9 
8 16.361 Silane, [(3.beta.)-cholesta-5,24-dien-3-yloxy]trimethyl- 4.9±0.4 
9 16.696 Silane, trimethyl[[(3.beta.,4.alpha.,5.alpha.)-4-methylcholesta-8,24-dien-
3-yl]oxy]- 
2.3±0.3 
10 18.354 Silane, [[(3.beta.,24R)-ergost-5-en-3-yl]oxy]trimethyl- 2.5±0.3 
11 19.292 Stigmasterol trimethylsilyl ether 0.6±0.0 
12 20.626 beta-Sitosterol 1.5±0.6 
13 21.532 beta.-Sitosterol trimethylsilyl ether 23.9±3.8 
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Figure Captions 
Fig.1. Satellite images showing the Mascarene region (A), Mauritius is located at  20.2000° S, 57.5000° E in the Indian 
Ocean (B), Research site map area of Amber Island located at 20°03'52.5"S and 57°41'19.7"E (C) (Source: Google Earth 
2016). 
 
Fig.2. GC-MS chromatogram of EAF of N. exigua. The inset shows the chemical structure of compounds 1, 5, 7 and 13. 
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Figure 1 
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Figure 2 
 
